Answers are grounded in this paper and cite their sources.
A patient suffering from the nevoid basal cell carcinoma syndrome, in whom various surgical and conservative treatment modalities had been tried previously, was placed on oral etretinate therapy. A therapeutic effect of the etretinate on existing basal cell carcinomas and a prophylactic effect in inhibiting new tumor formation were well demonstrated during the 13-month period of treatment.
No takes yet. Share an insight, caveat, or question.
Hodak et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: